SCHEMBL6019533

SCHEMBL6019533

CC(C)N1C[C@@H](C)[C@H]2CC[C@H](C)[C@H]2C1=O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33
DPP4 P27487 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018783 0.76
SCHEMBL12652864 0.72 MAPT (0.38) MAPTDPP4
SCHEMBL26498590 0.72
SCHEMBL6019489 0.71
SCHEMBL14104786 0.69 MAPT (0.36) MAPTDPP4
SCHEMBL6019364 0.69 ALDH1A1 (0.44) MAPT
SCHEMBL6019260 0.69 GBA1 (0.33)
SCHEMBL18821171 0.69 PIK3CD (0.52) MAPTDPP4
SCHEMBL16472435 0.69 PIK3CD (0.52) MAPTDPP4
SCHEMBL9251617 0.69 PIK3CD (0.52) MAPTDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060228387-A1 Dihydronepetalactams and N-substituted derivatives thereof E. I. DU PONT DE NEMOURS AND COMPANY 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060228387-A1 Dihydronepetalactams and N-substituted derivatives thereof NOTCH4, NRDC, BPHL MAPT 635/4885DPP4 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.